Yixintang chairman transfers shares to daughters, ensuring family ownership

Yixintang Pharmaceutical Group announced the completion of an internal share transfer by its controlling shareholder, Ruan Hongxian, to his daughters Ruan Shengxiang and Ruan Aixiang. The transfer, executed via block trade between December 15 and December 17, 2025, involved 11,637,300 shares (1.9872% of total share capital) at an average price of 11.31 yuan per share. This move follows an initial disclosure on November 7, 2025.

Post-transfer, Ruan Hongxian’s total holdings decreased from 31.1209% to 29.1337%. Ms. Ruan Shengxiang now holds 0.9873% and Ms. Ruan Aixiang holds 0.9999% of the company's total share capital. The parties have signed an "acting in concert agreement" effective until December 31, 2031.

The company stated that this internal transfer does not change the controlling shareholder or actual controller and will not impact the company's governance structure or ongoing operations. The transaction adheres to relevant securities laws and regulations, including those of the Shenzhen Stock Exchange.